Dergiler / Eurasian Journal of Medical Investigation / 2019 / Cilt: 3 - Sayı: 4

Apparent Regression of Symptoms of Alzheimer Disease Treated with a Combination of Medication and a Food Additive Mixture

Sayfa
343–346
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Rapid improvement in cognition followed withapparent return of memory to a surprising extent over a period of four months with improvement continuing to date.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:An unusual case of reduction in the symptoms of Alzheimer disease (AD) is described as a new finding showing unexpectedretention of memory.
📊
Temel Bulgular & Veri:Presenting with an NHS consultant diagnosis of vascular dementia in 2016 with no formaltreatment given, the patient, who was known to the author AC, started taking a specific food additive and supplementmixture in July 2017.
💡
Sonuç & Katkı:Rapid improvement in cognition followed withapparent return of memory to a surprising extent over a period of four months with improvement continuing to date.
🔬Tür:Araştırma Makalesi
📍Kapsam:2016 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

An unusual case of reduction in the symptoms of Alzheimer disease (AD) is described as a new finding showing unexpectedretention of memory. Presenting with an NHS consultant diagnosis of vascular dementia in 2016 with no formaltreatment given, the patient, who was known to the author AC, started taking a specific food additive and supplementmixture in July 2017. This was associated with some reduction of previous confirmed vascular dementia-related psychoticbehavior but no improvement in his seriously reduced cognition. In October 2017 the consultant diagnosis waschanged to vascular dementia with AD and medication with donepezil was commenced. One month later an enhancedfood additive mixture was also commenced in addition to donepezil. Rapid improvement in cognition followed withapparent return of memory to a surprising extent over a period of four months with improvement continuing to date.

🔖

Bu Makaleye Atıf Yap

CARMİCHAEL, A., GUPPY, M. (2022). Apparent Regression of Symptoms of Alzheimer Disease Treated with a Combination of Medication and a Food Additive Mixture. Eurasian Journal of Medical Investigation, Cilt: 3 - Sayı: 4, 343–346. https://ajindex.com/articles/508762

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Obulesu M, Lakshmi MJ. Apoptosis in Alzheimer's disease: an understanding of the physiology, pathology and therapeutic avenues. Neurochem Res 2014
  2. 2301–12. [CrossRef ] 2. Shoshan-Barmatz V, Nahon-Crystal E, Shteinfer-Kuzmine A, Gupta R. VDAC1, mitochondrial dysfunction, and Alzheimer's disease. Pharmacol Res 2018
  3. 87–101. [CrossRef ] 3. Reddy AS, Izmitli A, de Pablo JJ. Effect of trehalose on amyloid beta (29-40)-membrane interaction. J Chem Phys 2009
  4. 085101. [CrossRef ] 4. Palop JJ, Mucke L. Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci 2016
  5. 777–92. [CrossRef ] 5. Braak H, Del Trecidi K. Neuroanatomy and pathology of sporadic Alzheimer's disease. Adv Anat Embryol Cell Biol 2015
  6. 1–162. [CrossRef ] 6. Van Nassauw L, Adriaensen D, Timmermans JP. The bidirectional communication between neurons and mast cells within the gastrointestinal tract. Auton Neurosci 2007
  7. 91–103. 7. Collinge J. Mammalian prions and their wider relevance in neurodegenerative diseases. Nature 2016
  8. 217–26. [CrossRef] 8. Perez-Pardo P, Kliest T, Dodiya HB, Broersen LM, Garssen J, Keshavarzian A, et al. The gut-brain axis in Parkinson's disease: Possibilities for food-based therapies Eur J Pharmacol 2017
  9. 86–95. [CrossRef ] 9. Pokorski M, Marczak M, Dymecka A, Suchocki P. Ascorbyl palmitate as a carrier of ascorbate into neural tissues. J Biomed Sci 2003
  10. 193–8. [CrossRef ] 10. Tabak M, Armon R, Rosenblat G, Stermer E, Neeman I. Diverse effects of ascorbic acid and palmitoyl ascorbate on Helicobacter pylori survival and growth. FEMS Microbiol Lett 2003
  11. 247–53. [CrossRef ] 11. Mangal P, Khare P, Jagtap S, Bishnoi M, Kondepudi KK, Bhutani KK. Screening of six Ayurvedic medicinal plants for antiobesity potential: An investigation on bioactive constituents from Oroxylum indicum (L.) Kurz bark. J Ethnopharmacol 2017
  12. 138–46. [CrossRef ] 12. Buchholz T, Melzig MF. Polyphenolic Compounds as Pancreatic Lipase Inhibitors. Planta Medicine 2015
  13. 771–83. 13. Bialecka-Florjanczyk E, Fabiszewska AU, Krzyczkowska J, Kurylowicz A. Synthetic and Natural Lipase Inhibitors. Mini Rev Medicin Chem 2018
  14. 672–83. [CrossRef ] 14. Mazza M, Pomponi M, Janiri L, Bria P, Mazza S. Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview. Prog Neuropsychopharmacol Biol Psychiatry 2007
  15. 12–26. [CrossRef ] 15. Sowndhararajan K, Deepa P, Kim M, Park SJ, Kim S. Baicalein as a potent neuroprotective agen